Anti-Cancer frontier: Advances in Cancer research: Oncology Genomics, PhD in oncology, Samsung recommends

The author is a PhD in oncology, which focuses on the current forefront of targeted therapy and immunotherapy. Professionalism is no problem, easy to understand, than a similar book, "Cancer, Truth: Doctors are reading" to a lower gear. Overall rating Samsung.

Here is a excerpt from some of the important information in the book:

1: That is to say, if China's cancer care level catches up with the United States, we are likely to save the population of a city every year. #48

2: In reality, there is another case where a drug is approved for the treatment of a cancer, but the doctor may actually make the drug available to patients with B cancer. This usage is known as the label topical drug (Off-label drug use), which means that the drug is not used as required by the instructions. #151

3: As a milestone in the history of human medicine, the advent of imatinib has not only turned terminal illness into a treatable disease, but its research and development has provided a new paradigm for drug development, highlighting the importance of basic scientific research to human health. Imatinib is also the first small molecule targeted drug in the history of mankind. #208

4: Here's the flaw in targeting therapy. We also mentioned earlier that targeted therapy is useful if there is a "target" and no targeted therapy can be used by a patient without a target. Second, humans are still at a disadvantage to many of the current known molecular targets, that is, no suitable drugs can be found to target these targets. Finally, as with chemotherapy, targeted therapies do not prevent the recurrence of cancer and the emergence of resistance. #248

5: Not only the research related to cancer immunotherapy is increasing every year, but cancer immunotherapy is the most important scientific breakthrough of the Year in the 2013 by the famous academic periodical science. #272

6: However, the immune test point inhibitor is not without shortcomings, after all, we have not used a few years, many problems have not been solved. The first is that a large number of activated T cells can cause strong immune side effects. #328

7: Dendritic cell (DC) vaccines are a therapeutic type of cancer vaccine. It corresponds to a prophylactic cancer vaccine, such as the HPV vaccine to prevent cervical cancer. #402

Anti-Cancer frontier: Advances in Cancer research: Oncology Genomics, PhD in oncology, Samsung recommends